Lundbeck
HLUN-B.CO
#2719
Rank
C$9.13 B
Marketcap
C$9.21
Share price
0.19%
Change (1 day)
27.22%
Change (1 year)
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.

Earnings for Lundbeck (HLUN-B.CO)

Earnings in 2026 (TTM): C$1.18 Billion

According to Lundbeck's latest financial reports the company's current earnings are C$4.00 Billion. In 2025 the company made an earning of C$1.07 Billion, an increase over its 2024 earnings that were of C$0.77 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Lundbeck from 2009 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) C$1.18 B10.24%
2025 C$1.07 B37.43%
2024 C$0.77 B25.74%
2023 C$0.61 B21.77%
2022 C$0.50 B31.57%
2021 C$0.38 B-4.61%
2020 C$0.40 B-45.06%
2019 C$0.73 B-34.04%
2018 C$1.11 B12.83%
2017 C$0.99 B93.99%
2016 C$0.51 B-137.28%
2015 -C$1.38 Billion-1246.24%
2014 C$0.11 B-72.36%
2013 C$0.43 B4.38%
2012 C$0.41 B-55.18%
2011 C$0.92 B5.65%
2010 C$0.87 B-5.9%
2009 C$0.93 B